乌斯特基努马
克罗恩病
医学
疾病
重症监护医学
克罗恩病
免疫学
英夫利昔单抗
内科学
作者
Yumei Wu,Linlin Zhou,Mengqi Huang,Chengcheng Tian,Yu Wang,Qiming Huang,Jing Hu,Qiuyuan Liu,Juan Wu,Peipei Zhang,Qiao Mei,Wei Han
标识
DOI:10.1080/14712598.2025.2556909
摘要
This study demonstrated favorable effectiveness, persistence, and safety of UST in CD patients. Prior biologic exposure, early CRP reduction and hemoglobin level were associated with clinical remission at 52 weeks.
科研通智能强力驱动
Strongly Powered by AbleSci AI